JP2012532120A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532120A5
JP2012532120A5 JP2012518140A JP2012518140A JP2012532120A5 JP 2012532120 A5 JP2012532120 A5 JP 2012532120A5 JP 2012518140 A JP2012518140 A JP 2012518140A JP 2012518140 A JP2012518140 A JP 2012518140A JP 2012532120 A5 JP2012532120 A5 JP 2012532120A5
Authority
JP
Japan
Prior art keywords
shell structure
composition
drug
contrast agent
mpi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012518140A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532120A (ja
JP5763631B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/052918 external-priority patent/WO2011001351A1/en
Publication of JP2012532120A publication Critical patent/JP2012532120A/ja
Publication of JP2012532120A5 publication Critical patent/JP2012532120A5/ja
Application granted granted Critical
Publication of JP5763631B2 publication Critical patent/JP5763631B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012518140A 2009-07-01 2010-06-25 Ｍｐｉ誘導による薬物送達のための刺激応答性キャリア Expired - Fee Related JP5763631B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09164301.5 2009-07-01
EP09164301 2009-07-01
PCT/IB2010/052918 WO2011001351A1 (en) 2009-07-01 2010-06-25 Stimuli-responsive carriers for mpi-guided drug delivery

Publications (3)

Publication Number Publication Date
JP2012532120A JP2012532120A (ja) 2012-12-13
JP2012532120A5 true JP2012532120A5 (enExample) 2013-08-08
JP5763631B2 JP5763631B2 (ja) 2015-08-12

Family

ID=42847651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012518140A Expired - Fee Related JP5763631B2 (ja) 2009-07-01 2010-06-25 Ｍｐｉ誘導による薬物送達のための刺激応答性キャリア

Country Status (6)

Country Link
US (1) US20120100079A1 (enExample)
EP (1) EP2448557A1 (enExample)
JP (1) JP5763631B2 (enExample)
CN (1) CN102470098A (enExample)
RU (1) RU2561035C2 (enExample)
WO (1) WO2011001351A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9393198B2 (en) 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
CA2836904C (en) * 2011-06-03 2019-09-24 Signpath Pharma Inc. Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
US10449193B2 (en) 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
US12004868B2 (en) 2011-06-03 2024-06-11 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
WO2012169973A1 (en) * 2011-06-09 2012-12-13 Agency For Science, Technology And Research A core-shell nanoparticle
ITRM20120169A1 (it) 2012-04-19 2013-10-20 Consiglio Nazionale Ricerche Dispositivo di rilascio di specie chimiche a controllo ottico
CA2882978A1 (en) 2012-08-31 2014-03-06 University Of North Texas Health Science Center Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy
WO2014090313A1 (en) * 2012-12-13 2014-06-19 Universitaet Ulm Nanoparticle with a molecularly imprinted coating
JP2016509032A (ja) * 2013-02-20 2016-03-24 トパス ゲーエムベーハー Ｍｐｉを用いた消化管の診断検査用経口造影剤
CN103357027B (zh) * 2013-08-01 2016-02-10 孙博 一种具有mri示踪效应的纳米微囊
KR20150026613A (ko) * 2013-09-03 2015-03-11 삼성전자주식회사 소수성 물질 및 조영제를 포함하는 리포좀 및 그의 용도
CA2933204C (en) 2013-12-18 2020-04-28 Signpath Pharma, Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
GB201509934D0 (en) * 2015-06-08 2015-07-22 King S College London Nanoparticles
KR102603673B1 (ko) 2016-04-27 2023-11-17 사인패스 파마 인코포레이티드 약물 유발된 방실 차단의 방지
EP3484357B1 (en) 2016-07-12 2021-04-14 Magnetic Insight, Inc. Magnetic particle imaging using rotatable magnet
CN110352353B (zh) * 2017-03-03 2023-12-15 武田药品工业株式会社 确定腺相关病毒制剂的效价的方法
KR102024273B1 (ko) 2017-03-27 2019-11-04 주식회사 피에프디 약물 작용 관리 장치 및 방법
US11045552B2 (en) 2017-04-04 2021-06-29 International Business Machines Corporation Stimulus-responsive micellar carrier
CN107320738B (zh) * 2017-07-12 2020-06-12 福州大学 一种四氧化三锰-乳白蛋白纳米球及其制备与应用
JP6934833B2 (ja) 2018-03-30 2021-09-15 三菱パワー株式会社 水質モニタリングシステムとそれを備えた蒸気タービンシステム、並びに水質モニタリング方法
CN113747938A (zh) 2019-03-13 2021-12-03 马格内蒂克因赛特公司 磁性粒子致动器
CN112043682B (zh) * 2020-09-19 2022-03-11 新乡医学院 一种基于多孔钆掺杂氧化铁纳米簇的磁性纳米药物载体及其制备方法
US11839458B2 (en) 2021-02-08 2023-12-12 Vanberbilt University Magnetic particle imaging using an ultrasonic driving field

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411730A (en) * 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
US5534499A (en) 1994-05-19 1996-07-09 The University Of British Columbia Lipophilic drug derivatives for use in liposomes
US6726925B1 (en) 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
US6835394B1 (en) 1999-12-14 2004-12-28 The Trustees Of The University Of Pennsylvania Polymersomes and related encapsulating membranes
US7672704B2 (en) * 2002-09-11 2010-03-02 Duke University Methods and compositions for blood pool identification, drug distribution quantification and drug release verification
WO2005070400A1 (en) * 2004-01-15 2005-08-04 Mount Sinai School Of Medicine Methods and compositions for imaging
WO2005077330A1 (en) * 2004-02-17 2005-08-25 The University Of Melbourne Electromagnetic radiation addressable materials
EP1738773A1 (de) * 2005-06-29 2007-01-03 Schering AG Magnetische Eisenoxidpartikel enthaltende Zusammensetzung und deren Vervendung in bildgebenden Verfahren
TWI314465B (en) * 2005-12-30 2009-09-11 Ind Tech Res Inst Thermosensitive nanostructure for hyperthermia treatment
CZ301067B6 (cs) * 2006-02-24 2009-10-29 Ústav makromolekulární chemie AV CR Superparamagnetické nanocástice na bázi oxidu železa s modifikovaným povrchem, zpusob jejich prípravy a použití
KR20080035926A (ko) * 2006-10-20 2008-04-24 재단법인서울대학교산학협력재단 자성체 나노입자를 함유한 코어-외각 구조의 금 나노입자의자기공명영상의 티2 조영제, 암 진단제 및 암치료제로서의 용도
WO2008099346A1 (en) * 2007-02-16 2008-08-21 Koninklijke Philips Electronics N. V. Method and separator system for separating magnetic particles, separator column for use in a separator system
JP2009051752A (ja) * 2007-08-24 2009-03-12 Hitachi Ltd 磁性粒子含有薬剤キャリア及びそれを用いた治療装置
WO2009126441A1 (en) * 2008-04-10 2009-10-15 Board Of Regents, The University Of Texas System Compositions and methods for thermo-sensitive nanoparticles and magnetic nanoparticles
TWI374761B (en) * 2008-05-13 2012-10-21 Univ Nat Chiao Tung Method for forming a drug container having the magnetic nano single-crystalline capsule

Similar Documents

Publication Publication Date Title
JP2012532120A5 (enExample)
RU2012103347A (ru) Восприимчивые к стимулирующему фактору носители для вмч-регулируемой доставки лекарственного средства
JP2015532928A5 (enExample)
Hanif et al. Halloysite nanotubes as a new drug-delivery system: a review
Sharma et al. An insight into functionalized calcium based inorganic nanomaterials in biomedicine: Trends and transitions
Shah et al. Thermo-responsive copolymer coated MnFe2O4 magnetic nanoparticles for hyperthermia therapy and controlled drug delivery
Sun et al. Nano‐biomedicine based on liquid metal particles and allied materials
JP2010132694A5 (enExample)
Sharma et al. Gd nanoparticulates: from magnetic resonance imaging to neutron capture therapy
JP2011525477A5 (enExample)
JP2013503831A5 (enExample)
JP2009534350A (ja) 磁性ナノ粒子組成物およびその使用
WO2012121528A3 (en) Magnetic nanocomposite specific for thyroid cancer and use thereof
Wang et al. Magnetic and fluorescent carbon-based nanohybrids for multi-modal imaging and magnetic field/NIR light responsive drug carriers
JP2011524890A5 (enExample)
JP2016505006A5 (enExample)
Xu et al. Advances in brain tumor therapy based on the magnetic nanoparticles
JP2015522548A (ja) ツーピース硬カプセル用の耐酸性バンド溶液
JP2010536898A5 (enExample)
Dunn et al. Recent developments in the design of nanomaterials for photothermal and magnetic hyperthermia induced controllable drug delivery
CN105097170A (zh) 一种磁性纳米粒子、制备方法及其应用
TWI674114B (zh) 醫藥組合物、製備方法及其用途
ITTV20130027A1 (it) Procedimento per la produzione di particelle sub-micrometriche e loro uso teranostico in oncologia con una specifica apparecchiatura.
CN103181915B (zh) 具有中空夹层的纳米胶囊的制备方法
WO2008125259A3 (en) Super paramagnetic iron oxide nanoparticle coupled tissue soldering